After years of promise, PRM seems to be on the verge of a breakthrough into the big league. Deals have been signed in the last six months which will commercialise their stroke and bse tests into markets worth hundreds of million pounds and Sensitizer, their protein profiling toolkit, is tipped to be snapped up for big money royalties. Their 30% of Intronn Inc could be pure gold and their 60%+ of Veri-q has been described as a potential cash cow. And that's just for starters.

I am told that the large trades today is just some in-house book keeping going on by an institution..the real news about the major licencing deal will be announced in the very near future!...my target price is at least 75p..maybe even 1 on the news..we will have to see...